INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $18,000 | -50.0% | 16,200 | +0.6% | 0.00% | – |
Q4 2021 | $36,000 | -34.5% | 16,100 | 0.0% | 0.00% | – |
Q3 2021 | $55,000 | +14.6% | 16,100 | 0.0% | 0.00% | – |
Q2 2021 | $48,000 | -86.5% | 16,100 | -85.4% | 0.00% | – |
Q1 2017 | $355,000 | +136.7% | 110,000 | -1.2% | 0.00% | – |
Q4 2016 | $150,000 | -14.3% | 111,300 | -0.8% | 0.00% | – |
Q3 2016 | $175,000 | +17.4% | 112,210 | 0.0% | 0.00% | – |
Q2 2016 | $149,000 | -59.2% | 112,210 | +62.1% | 0.00% | – |
Q1 2016 | $365,000 | -32.8% | 69,210 | 0.0% | 0.00% | – |
Q4 2015 | $543,000 | -19.0% | 69,210 | -12.7% | 0.00% | -100.0% |
Q3 2015 | $670,000 | -57.6% | 79,310 | -45.0% | 0.00% | 0.0% |
Q2 2015 | $1,580,000 | +42.3% | 144,330 | +81.8% | 0.00% | 0.0% |
Q1 2015 | $1,110,000 | -17.2% | 79,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,341,000 | +25.8% | 79,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,066,000 | +1.0% | 79,400 | -4.1% | 0.00% | 0.0% |
Q2 2014 | $1,055,000 | +7.2% | 82,800 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $984,000 | -18.9% | 82,800 | -5.8% | 0.00% | 0.0% |
Q4 2013 | $1,214,000 | -27.3% | 87,900 | -8.1% | 0.00% | -50.0% |
Q3 2013 | $1,669,000 | -7.3% | 95,662 | -13.6% | 0.00% | 0.0% |
Q2 2013 | $1,800,000 | – | 110,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |